Conavi Medical Presents Data Demonstrating Feasibility of Saline-Based Hybrid IVUS–OCT Imaging with OCTIV™ at TCT 2026

Impact · against what's priced in

Conavi Medical's transition to commercial clinical use in the U.S. and the potential for saline-based imaging provide tangible growth catalysts. The ability to operate without iodinated contrast could expand the total addressable market by including patients with renal insufficiency.

CNVI+0.50

No priced-in read yet